ClinicalTrials.Veeva

Menu

A Study Based on the French National Health Insurance Database in Participants With Psychotic Disorders

Eisai logo

Eisai

Status

Completed

Conditions

Psychotic Disorders

Treatments

Other: No Intervention

Study type

Observational

Funder types

Industry

Identifiers

NCT05633108
LOX-M033-501

Details and patient eligibility

About

The primary purpose of the study is to compare therapy with antipsychotic medication (antipsychotic monotherapy or antipsychotic combination) versus no antipsychotic medication, and antipsychotic monotherapy versus antipsychotic combination, regarding time to psychiatric rehospitalization, in participants with a psychotic disorder (that is, schizophrenia, schizotypal disorders, schizoaffective disorders, persistent or acute or induced or non-organic delusional disorders, recurrent depressive disorder with psychotic symptoms).

Enrollment

579,728 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • At least one discharge for psychiatric hospitalization with a diagnosis of a psychotic disorder between January 1, 2014 and December 31, 2020.
  • At least one long-term disease record (LTD), (which is a French administrative status allowing the full reimbursement of the cost of a chronic pathology) with a diagnosis of a psychotic disorder between January 1, 2014 and December 31, 2020.
  • Age of 18 years or older at index date (first date found in the previous conditions).

Exclusion criteria

• Due to data management constraint, the participants with multiple or temporary identifiers in the database (indistinguishable in database) will be excluded. This happens with twins or migrants, for example.

Trial design

579,728 participants in 1 patient group

All Participants
Description:
Participants diagnosed with psychotic disorder at any time between 1 January 2014 and 31 December 2020 and have data available in French nationwide healthcare data system (SNDS) database during this period will be observed retrospectively.
Treatment:
Other: No Intervention

Trial contacts and locations

1

Loading...

Central trial contact

Eisai Medical Information

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems